The Future of British Hemp
Join the UK's first precision-bred hemp genetics company. Government-backed technology, massive market opportunity, and significant tax benefits for qualifying investors.
Investor Portal
Access exclusive investment materials and detailed market data
What's Inside
- Detailed market analysis & financial projections
- EU & global hemp farming statistics
- Government backing from 30+ countries
- SEIS/EIS tax benefit calculator
- Funding history & use of funds breakdown
- Exit scenarios & competitive analysis
Already have a PIN? Enter here
Why invest in Precision Plants?
Precision Plants is developing the UK's first precision-bred, THC-free hemp varieties using CRISPR gene editing, targeting a global industrial hemp market projected to reach $18.6 billion by 2027 (CAGR 22.4%). The company qualifies for SEIS (50% income tax relief) and EIS (30% income tax relief) under HMRC advance assurance, with additional capital gains tax exemption on qualifying shares — providing up to 78% effective tax relief for eligible investors.
Backed by £912,000 in DEFRA government funding and a research partnership with Rothamsted Research, Precision Plants is the only UK company with precision-bred hemp genetics. The Precision Breeding Act 2023 provides a clear regulatory pathway, and UK hemp hectarage is targeted to triple by 2030 under government policy. — Grand View Research 2024
Why Invest in Precision Plants?
We're developing the UK's first precision-bred hemp varieties (10-13 CRISPR edits per variety), solving the critical THC compliance problem that has held back British hemp farming for decades. With government backing, exclusive research partnerships, and a clear regulatory pathway, we're positioned to capture a significant share of a rapidly growing market.